Infectious Disease

Using Clinical Data to Combat Influenza in Older Adults

This is a 30-minute CCCEP certified eCME program for Canadian pharmacists. The goal is to provide education on the burden of influenza, and influenza prevention and control measures, with a focus on older adults, and the clinical data used to support vaccination options for this high-risk population. This program is designed to provide practical information on the available influenza vaccines in Canada, and national recommendations in order to support discussions with older adults on the optimal protection available to them.

DURATION

30 min

PROFESSION

Pharmacy

# OF CREDITS

1.70

ACCREDITATION

CCCEP, OPQ

EXPIRY DATE

2025-08-30

Influenza virus infection causes a wide spectrum of illness and presents an ongoing disease burden in Canada during the fall and winter months. Risk groups for influenza-related complications or hospitalization include older adults (≥ 65 years old), young children, pregnant persons, and individuals with certain chronic health conditions. Older adults represent the majority of hospitalizations, ICU admissions and deaths from influenza infection annually in Canada. Vaccination against influenza is crucial for older adults as it helps bolster their immune response, and reduces the likelihood of severe illness, hospitalization, morbidity and mortality. As such, adults 65 years of age and older are prioritized to receive influenza vaccines because of the increased risks of severe disease in this population. Inactivated high-dose, adjuvanted or recombinant influenza vaccines are recommended, when available, over other influenza vaccines for adults 65 years of age and older. This program will provide participants with key information about the three vaccines indicated for older adults in Canada, including an analysis of the data used to support the preferential recommendation for these vaccines. The goal is to inform discussions on how to optimize influenza protection among older adults in Canada.


This program has received an educational grant or in-kind support from Sanofi.

Faculty

Mark Loeb, MSc, MD, FRCPC

Susie Jin, RPh, CDE, CRE

Kristen Watt, BSc Phm, RPh

Learning objectives

Upon completion of this continuing education program participants will be better able to:

  • Describe the burden of influenza in older adults and the importance of influenza vaccination
  • Apply NACI 2024-2025 recommendations for influenza vaccination and concurrent administration with other vaccines in older adults
  • Implement influenza vaccination in clinical practice

Accreditation

This continuing education lesson is designed primarily for pharmacists and has been accredited by the Canadian Council on Continuing Education in Pharmacy (CCCEP) for 1.70 CEU(s).
CCCEP File Number: 1066-2024-3840-I-P

This continuing educational activity has been accredited by the OPQ; 0.5 continuing education units/credits will be awarded to pharmacists who successfully complete the program. 
Accreditation number: 240054

Cost of course:  
Free
# of credits: 1.70
Duration: 30 min

FAQs & HELP

MDBriefCase Group specializes in accredited, online continuing professional development (CPD) programs, custom tailored for specific international markets and available on a convenient online platform.

All content is developed by leading specialists and peer-reviewed by experts at respected institutions, which keeps more than 280,000 global healthcare professionals at the forefront of the latest evidence and protocols worldwide.

The vast majority of our programs are accredited by one or more respected institutions. We do provide unaccredited content to ensure that healthcare professionals have access to relevant practical resources in addition to accredited learning.

Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.

MDBriefCase Group works with various institutions to provide peer-reviewed, up-to-date accredited content. Our programs and resources are provided via collaboration between medical writers, faculty members, associations, universities and other relevant organizations. The content you were recommended is likely valued by your society or association and is conveniently provided to you free of charge on an MDBriefCase Group platform.

Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.

No, registration with MDBriefCase is free!

To access your profile, visit My Profile. If you would like to update the information here don’t forget to hit the ‘save’ button when you are finished. Your profile is where you can control what email communications you receive.

If you have forgotten your password, you can reset your password. To access this page from the Login page, click Forgot password. Enter the email address you registered with and you will receive an email with a link to reset your password.

Please note: if you submitted multiple password resets, only the link on the most recent email is valid.

You can unsubscribe from MDBriefCase Group emails by clicking the unsubscribe button located at the bottom of each of our emails.

Using Clinical Data to Combat Influenza in Older Adults

30 min

Duration

Pharmacy

Profession

1.70

# of credits

Learning Objectives

Upon completion of this continuing education program participants will be better able to:

  • Describe the burden of influenza in older adults and the importance of influenza vaccination
  • Apply NACI 2024-2025 recommendations for influenza vaccination and concurrent administration with other vaccines in older adults
  • Implement influenza vaccination in clinical practice

CCCEP
Accredited
Course

CCCEP, OPQ

ACCREDITATION

Infectious Disease

Learning Category

Influenza, Vaccinations, Infectious Disease

Topic

0

Price

2025-08-30

Expiry Date

CAN-eng

Region/Language

Course Description

Influenza virus infection causes a wide spectrum of illness and presents an ongoing disease burden in Canada during the fall and winter months. Risk groups for influenza-related complications or hospitalization include older adults (≥ 65 years old), young children, pregnant persons, and individuals with certain chronic health conditions. Older adults represent the majority of hospitalizations, ICU admissions and deaths from influenza infection annually in Canada. Vaccination against influenza is crucial for older adults as it helps bolster their immune response, and reduces the likelihood of severe illness, hospitalization, morbidity and mortality. As such, adults 65 years of age and older are prioritized to receive influenza vaccines because of the increased risks of severe disease in this population. Inactivated high-dose, adjuvanted or recombinant influenza vaccines are recommended, when available, over other influenza vaccines for adults 65 years of age and older. This program will provide participants with key information about the three vaccines indicated for older adults in Canada, including an analysis of the data used to support the preferential recommendation for these vaccines. The goal is to inform discussions on how to optimize influenza protection among older adults in Canada.


This program has received an educational grant or in-kind support from Sanofi.

Faculty

Mark Loeb, MSc, MD, FRCPC

Susie Jin, RPh, CDE, CRE

Kristen Watt, BSc Phm, RPh

Accreditation

This continuing education lesson is designed primarily for pharmacists and has been accredited by the Canadian Council on Continuing Education in Pharmacy (CCCEP) for 1.70 CEU(s).
CCCEP File Number: 1066-2024-3840-I-P

This continuing educational activity has been accredited by the OPQ; 0.5 continuing education units/credits will be awarded to pharmacists who successfully complete the program. 
Accreditation number: 240054